{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:46:12Z","timestamp":1793033172574,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.exppara.2013.01.022","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T14:25:16Z","timestamp":1361283916000},"page":"68-75","source":"Crossref","is-referenced-by-count":23,"title":["Susceptibility of clinical isolates of Leishmania aethiopica to miltefosine, paromomycin, amphotericin B and sodium stibogluconate using amastigote-macrophage in vitro model"],"prefix":"10.1016","volume":"134","author":[{"given":"M.","family":"Utaile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kassahun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Abebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.exppara.2013.01.022_b0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0166-6851(87)90146-0","article-title":"Cytotoxicity of ester and ether lysophospholipids on Leishmania donovani promastigotes","volume":"23","author":"Achterberg","year":"1987","journal-title":"Mol. Biochem. Parasitol."},{"issue":"2","key":"10.1016\/j.exppara.2013.01.022_b0010","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.10.2.298","article-title":"Leishmania and human immunodeficiency virus coinfection: the first 10years","volume":"10","author":"Alvar","year":"1997","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.exppara.2013.01.022_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actatropica.2007.08.003","article-title":"Mucosal leishmaniasis. Current scenario and prospects for treatment. [Review]","volume":"105","author":"Amato","year":"2008","journal-title":"Acta Trop."},{"issue":"16","key":"10.1016\/j.exppara.2013.01.022_b0020","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1517\/14656566.8.16.2689","article-title":"Cutaneous leishmaniasis: therapeutic strategies and future directions","volume":"8","author":"Ameen","year":"2007","journal-title":"Expert Opin. Pharmacother."},{"issue":"4","key":"10.1016\/j.exppara.2013.01.022_b0025","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0035-9203(73)90088-6","article-title":"The epidemiology of cutaneous leishmaniasis in Ethiopia","volume":"67","author":"Ashford","year":"1973","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"5","key":"10.1016\/j.exppara.2013.01.022_b0030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00001432-200310000-00005","article-title":"Current treatment approaches to leishmaniasis","volume":"16","author":"Berman","year":"2003","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.exppara.2013.01.022_b0035","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1517\/17425255.4.9.1209","article-title":"Treatment of leishmaniasis with miltefosine: 2008 status","volume":"4","author":"Berman","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"3 Pt 1","key":"10.1016\/j.exppara.2013.01.022_b0040","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4269\/ajtmh.1982.31.459","article-title":"Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro","volume":"31","author":"Berman","year":"1982","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"4","key":"10.1016\/j.exppara.2013.01.022_b0045","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/AAC.41.4.818","article-title":"An axenic amastigote system for drug screening","volume":"41","author":"Callahan","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.exppara.2013.01.022_b0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0001-706X(01)00125-5","article-title":"In vitro activity of pentavalent antimony derivatives on promastigotes and intracellular amastigotes of Leishmania infantum strains from humans and dogs in Spain","volume":"79","author":"Carrio","year":"2001","journal-title":"Acta Trop."},{"issue":"11","key":"10.1016\/j.exppara.2013.01.022_b0055","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1365-3156.2001.00754.x","article-title":"Monitoring drug resistance in leishmaniasis","volume":"6","author":"Croft","year":"2001","journal-title":"Trop. Med. Int. Health"},{"issue":"11","key":"10.1016\/j.exppara.2013.01.022_b0060","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis\u2013current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol."},{"issue":"6","key":"10.1016\/j.exppara.2013.01.022_b0065","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/jac\/38.6.1041","article-title":"The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei","volume":"38","author":"Croft","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl 1","key":"10.1016\/j.exppara.2013.01.022_b0070","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/S0035-9203(02)90063-5","article-title":"Drug sensitivity of Leishmania species: some unresolved problems","volume":"96","author":"Croft","year":"2002","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"7","key":"10.1016\/j.exppara.2013.01.022_b0075","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.trstmh.2008.09.008","article-title":"Paromomycin","volume":"103","author":"Davidson","year":"2009","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"2","key":"10.1016\/j.exppara.2013.01.022_b0215","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/tropej\/fmp073","article-title":"Successful treatment of childhood cutaneous leishmaniasis with liposomal amphotericin B: report of two cases","volume":"56","author":"del Rosal","year":"2010","journal-title":"J Trop Pediatr"},{"issue":"2","key":"10.1016\/j.exppara.2013.01.022_b0085","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1128\/AAC.01183-07","article-title":"Modulation of gene expression in human macrophages treated with the anti-leishmania pentavalent antimonial drug sodium stibogluconate","volume":"52","author":"El Fadili","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.exppara.2013.01.022_b0090","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.exppara.2006.12.004","article-title":"Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod","volume":"116","author":"El-On","year":"2007","journal-title":"Exp. Parasitol."},{"issue":"2","key":"10.1016\/j.exppara.2013.01.022_b0095","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0001-706X(01)00197-8","article-title":"Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B. [Research Support, Non-U.S. Gov\u2019t]","volume":"81","author":"Escobar","year":"2002","journal-title":"Acta Trop."},{"issue":"3","key":"10.1016\/j.exppara.2013.01.022_b0100","article-title":"Evaluation of miltefosine against leishmania MAJOR (MRHO\/IR\/75\/ER): in vitro and in vivo studies","volume":"46","author":"Esmaeili","year":"2008","journal-title":"Acta Med. Iran."},{"issue":"4","key":"10.1016\/j.exppara.2013.01.022_b0105","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.exppara.2006.09.014","article-title":"Leishmania (Kinetoplastida): species typing with isoenzyme and PCR-RFLP from cutaneous leishmaniasis patients in Ethiopia","volume":"115","author":"Gadisa","year":"2007","journal-title":"Exp. Parasitol."},{"issue":"3\u20134","key":"10.1016\/j.exppara.2013.01.022_b0110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0001-706X(92)90042-V","article-title":"An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1","volume":"51","author":"Gebre-Hiwot","year":"1992","journal-title":"Acta Trop."},{"issue":"1","key":"10.1016\/j.exppara.2013.01.022_b0115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0035-9203(03)00008-7","article-title":"The isolation of Leishmania tropica and L. aethiopica from Phlebotomus (Paraphlebotomus) species (Diptera: Psychodidae) in the Awash Valley, northeastern Ethiopia","volume":"98","author":"Gebre-Michael","year":"2004","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2013.01.022_b0120","first-page":"CD005067","article-title":"Interventions for old world cutaneous leishmaniasis","volume":"4","author":"Gonzalez","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.exppara.2013.01.022_b0125","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.exppara.2009.06.013","article-title":"Host peroxisomal properties are not restored to normal after treatment of visceral leishmaniasis with sodium antimony gluconate","volume":"123","author":"Gupta","year":"2009","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2013.01.022_b0130","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2210-3-6","article-title":"In vitro antileishmanial effects of antibacterial diterpenes from two Ethiopian Premna species: P. schimperi and P. oligotricha","volume":"3","author":"Habtemariam","year":"2003","journal-title":"BMC Pharmacol."},{"issue":"5","key":"10.1016\/j.exppara.2013.01.022_b0135","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1371\/journal.pmed.0030162","article-title":"Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites","volume":"3","author":"Hadighi","year":"2006","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.exppara.2013.01.022_b0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.trstmh.2005.04.017","article-title":"Isolation of Leishmania tropica from an Ethiopian cutaneous leishmaniasis patient","volume":"100","author":"Hailu","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"2","key":"10.1016\/j.exppara.2013.01.022_b0145","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1371\/journal.pntd.0000381","article-title":"Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? a meta-analysis of 14 randomized controlled trials","volume":"3","author":"Kim","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/j.exppara.2013.01.022_b0150","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/AAC.01233-08","article-title":"In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity","volume":"53","author":"Kumar","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2013.01.022_b0155","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-4899-0179-8_33","article-title":"Ether lipid metabolism, GPI anchor biosynthesis, and signal transduction are putative targets for anti-leishmanial alkyl phospholipid analogues","volume":"416","author":"Lux","year":"1996","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.exppara.2013.01.022_b0160","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tmaid.2006.09.004","article-title":"Cutaneous leishmaniasis treatment","volume":"5","author":"Minodier","year":"2007","journal-title":"Travel Med. Infect. Dis."},{"issue":"10","key":"10.1016\/j.exppara.2013.01.022_b0165","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2174\/092986707780362862","article-title":"Chemotherapy of leishmaniasis: past, present and future","volume":"14","author":"Mishra","year":"2007","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.exppara.2013.01.022_b0170","first-page":"60","article-title":"Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis","volume":"16","author":"Munir","year":"2008","journal-title":"Acta Dermatovenerol. Croat."},{"issue":"5","key":"10.1016\/j.exppara.2013.01.022_b0175","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jac\/35.5.577","article-title":"The sensitivity of Leishmania species to aminosidine","volume":"35","author":"Neal","year":"1995","journal-title":"J. Antimicrob. Chemother."},{"issue":"4\u20135","key":"10.1016\/j.exppara.2013.01.022_b0180","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drup.2004.07.002","article-title":"Leishmaniasis: drugs in the clinic, resistance and new developments","volume":"7","author":"Ouellette","year":"2004","journal-title":"Drug Resist. Updat."},{"issue":"2","key":"10.1016\/j.exppara.2013.01.022_b0185","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0166-6851(99)00216-9","article-title":"Genetic variability within the species Leishmania aethiopica does not correlate with clinical variations of cutaneous leishmaniasis","volume":"106","author":"Schonian","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"issue":"1","key":"10.1016\/j.exppara.2013.01.022_b0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parint.2006.09.001","article-title":"Advances and perspectives in Leishmania cell based drug-screening procedures","volume":"56","author":"Sereno","year":"2007","journal-title":"Parasitol. Int."},{"issue":"2","key":"10.1016\/j.exppara.2013.01.022_b0195","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4269\/ajtmh.2008.78.210","article-title":"Efficacy of miltefosine for Bolivian cutaneous leishmaniasis. [Randomized Controlled Trial]","volume":"78","author":"Soto","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"4","key":"10.1016\/j.exppara.2013.01.022_b0200","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.exppara.2013.01.022_b0205","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4269\/ajtmh.2005.73.272","article-title":"The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine","volume":"73","author":"Yardley","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"8","key":"10.1016\/j.exppara.2013.01.022_b0210","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1086\/507710","article-title":"American tegumentary leishmaniasis: is antimonial treatment outcome related to parasite drug susceptibility?","volume":"194","author":"Yardley","year":"2006","journal-title":"J. Infect. Dis."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489413000453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489413000453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T18:23:29Z","timestamp":1562696609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489413000453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0014489413000453"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2013.01.022","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}